Evidence map›Paper›PMID 19090984›Full record

ArticleBMC neuroscience2008

Allopregnanolone-induced rise in intracellular calcium in embryonic hippocampal neurons parallels their proliferative potential.

Jun Ming Wang, Roberta Diaz Brinton

Open access · goldAbstract read
In one paragraph

Article in BMC neuroscience, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. GABADrug design, development and therapy · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Golexanolone, a GABACNS neuroscience & therapeutics · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer's Mouse Model.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Allopregnanolone and neurogenesis in the nigrostriatal tract.Frontiers in cellular neuroscience · 2014
    Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jun Ming WangDepartment of Pharmacology and Pharmaceutical Sciences and Program in Neuroscience, University of Southern California, Los Angeles, CA 90089, USA. jwang@pathology.umsmed.edu
Roberta Diaz Brinton
Jackson Memorial Hospital · USUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFactors that regulate intracellular calcium concentration are known to play a critical role in brain function and neural development, including neural plasticity and neurogenesis. We previously demonstrated that the neurosteroid allopregnanolone (APalpha; 5alpha-pregnan-3alpha-ol-20-one) promotes neural progenitor proliferation in vitro in cultures of rodent hippocampal and human cortical neural progenitors, and in vivo in triple transgenic Alzheimer's disease mice dentate gyrus. We also found that APalpha-induced proliferation of neural progenitors is abolished by a calcium channel blocker, nifedipine, indicating a calcium dependent mechanism for the proliferation.

methodsIn the present study, we investigated the effect of APalpha on the regulation of intracellular calcium concentration in E18 rat hippocampal neurons using ratiometric Fura2-AM imaging.

resultsResults indicate that APalpha rapidly increased intracellular calcium concentration in a dose-dependent and developmentally regulated manner, with an EC50 of 110 +/- 15 nM and a maximal response occurring at three days in vitro. The stereoisomers 3beta-hydroxy-5alpha-hydroxy-pregnan-20-one, and 3beta-hydroxy-5beta-hydroxy-pregnan-20-one, as well as progesterone, were without significant effect. APalpha-induced intracellular calcium concentration increase was not observed in calcium depleted medium and was blocked in the presence of the broad spectrum calcium channel blocker La3+, or the L-type calcium channel blocker nifedipine. Furthermore, the GABAA receptor blockers bicuculline and picrotoxin abolished APalpha-induced intracellular calcium concentration rise.

conclusionCollectively, these data indicate that APalpha promotes a rapid, dose-dependent, stereo-specific, and developmentally regulated increase of intracellular calcium concentration in rat embryonic hippocampal neurons via a mechanism that requires both the GABAA receptor and L-type calcium channel. These data suggest that APalpha-induced intracellular calcium concentration increase serves as the initiation mechanism whereby APalpha promotes neurogenesis.

Indexed as

AnestheticsAnimalsBicucullineCalciumCalcium Channel BlockersCalcium Channels, L-TypeCell ProliferationCells, CulturedCytoplasmFemaleGABA AntagonistsHippocampusNeuronsNifedipinePicrotoxinPregnancyAnestheticsBicucullineCalciumCalcium Channel BlockersCalcium Channels, L-TypeGABA AntagonistsNifedipinePicrotoxinPregnanolone

Identifiers

PMID19090984
PMCPMC2604895
OpenAlexW1963508478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.